Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1641 1677 1678 1758 1787 1796
This examiner grants 59% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18251926 | AUTOANTIBODIES AS BIOMARKERS FOR LIPODYSTROPHY | Final Rejection | The Regents of the University of California |
| 18158768 | Biomarkers for identifying e-cigarette, or vaping, product use-associated lung injury | Non-Final OA | University of Rochester |
| 17595478 | REAGENTS FOR SANDWICH IMMUNOASSAYS USING PARTICLE ENHANCED AGGLUTINATION DETECTION AND METHODS OF PRODUCTION AND USE THEREOF | Non-Final OA | Siemens Healthcare Diagnostics Inc. |
| 18339108 | NANO-LIGAND FOR PROMOTING CELL ADHESION AND DIFFERENTIATION OF STEM CELLS AND METHOD OF PROMOTING CELL ADHESION AND DIFFERENTIATION OF STEM CELLS BY USING THE SAME | Non-Final OA | Korea University Research and Business Foundation |
| 17633720 | METHODS FOR MONITORING OR PREDICTING RESPONSE TO IMMUNOTHERAPIES FOR GYNECOLOGIC CANCER | Final Rejection | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA |
| 18561621 | sFRP4 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ADENOMYOSIS | Final Rejection | Roche Diagnostics Operations, Inc. |
| 17772959 | SEPSIS MANAGEMENT | Non-Final OA | ROCHE DIAGNOSTICS OPERATIONS, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy